Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Phase 2/3 × FED × Imiquimod × Clear all

Phase

Phase 2/3 2 Phase EARLY_PHASE1 1

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 2

Sponsor

Cancer Type

Conditions

Uterine Cervical Dysplasia 1 Bowen's Disease 1

Interventions

Imiquimod 2 Thioctic Acid 1 Picibanil 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02130323 2017-06-27

Topical Imiquimod vs. LEEP for Women With Carcinoma In-situ of the Cervix

United States Naval Medical Center, San Diego

Phase 2/3 Completed

Uterine Cervical Dysplasia

NCT00384124 2008-03-26

Topical Imiquimod for Bowen's Disease of the Head and Neck

Brooke Army Medical Center

Phase 2/3 Unknown

Bowen's Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡